Publications | Salami Lab

publication

Key Publications

Explore high impact publications from the Salami Lab.

Check our GitHub repositories

Key Publications

 Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma.

Monda SM, Nallandhighal S, Vaishampayan U, Singhal U, Knuth Z, Mehra R, Kaffenberger S, Hafez K, Udager AM, Palapattu GS, Morgan TM, Salami SS.

JCO Precis Oncol. 2025 Jun;9:e2500213. doi: 10.1200/PO-25-00213. Epub 2025 Jun 6. PMID: 40479621

 Spatial Transcriptomic Profiling to Characterize the Nature of Peripheral- Versus Transition-zone Prostate Cancer.

Patel P, Nallandhighal S, Scoville D, Cotta B, Knuth Z, Triner D, Tran L, Udager AM, Rao A, Morgan TM, Palapattu GS, Dadhania V, Pitchiaya S, Salami SS.

Eur Urol Focus. 2025 Mar;11(2):226-234. doi: 10.1016/j.euf.2024.11.009. Epub 2024 Nov 29.

PMID: 39613543

 Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.

Mehra R, Nallandhighal S, Cotta B, Knuth Z, Su F, Kasputis A, Zhang Y, Wang R, Cao X, Udager AM, Dhanasekaran SM, Cieslik MP, Morgan TM, Salami SS.

JCO Precis Oncol. 2024 May;8:e2300565. doi: 10.1200/PO.23.00565. PMID: 38810179 

 Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis.

Singhal U, Nallandhighal S, Tosoian JJ, Hu K, Pham TM, Stangl-Kremser J, Liu CJ, Karim R, Plouffe KR, Morgan TM, Cieslik M, Lucianò R, Shariat SF, Finocchio N, Dambrosio L, Doglioni C, Chinnaiyan AM, Tomlins SA, Briganti A, Palapattu GS, Udager AM, Salami SS.

Nat Commun. 2024 May 21;15(1):4341. doi: 10.1038/s41467-024-48629-y. PMID: 38773085

 Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype.

Farha M, Nallandhighal S, Vince R, Cotta B, Stangl-Kremser J, Triner D, Morgan TM, Palapattu GS, Cieslik M, Vaishampayan U, Udager AM, Salami SS.

Cancers (Basel). 2023 Nov 22;15(23):5530. doi: 10.3390/cancers15235530.

PMID: 38067234 

 Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.

Cotta BH, Choueiri TK, Cieslik M, Ghatalia P, Mehra R, Morgan TM, Palapattu GS, Shuch B, Vaishampayan U, Van Allen E, Ari Hakimi A, Salami SS.

Eur Urol. 2023 Aug;84(2):166-175. doi: 10.1016/j.eururo.2023.04.003. Epub 2023 Apr 19.

PMID: 37085424 

 Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.

Nallandhighal S, Vince R, Karim R, Groves S, Stangl-Kremser J, Russell C, Hu K, Pham T, Cani AK, Liu CJ, Zaslavsky A, Mehra R, Cieslik M, Morgan TM, Palapattu GS, Udager AM, Salami SS.

Eur Urol Oncol. 2022 Feb;5(1):92-99. doi: 10.1016/j.euo.2021.10.007. Epub 2021 Nov 26.

PMID: 34840106

 Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.

Cani AK, Hu K, Liu CJ, Siddiqui J, Zheng Y, Han S, Nallandhighal S, Hovelson DH, Xiao L, Pham T, Eyrich NW, Zheng H, Vince R Jr, Tosoian JJ, Palapattu GS, Morgan TM, Wei JT, Udager AM, Chinnaiyan AM, Tomlins SA, Salami SS.

Eur Urol Oncol. 2022 Aug;5(4):430-439. doi: 10.1016/j.euo.2021.03.002. Epub 2021 Mar 31.

PMID: 33812851 

 Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study.

Salami SS, Tosoian JJ, Nallandhighal S, Jones TA Jr, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, Tomlins SA, Udager AM, Sisk AE Jr, Marks LS, Palapattu GS.

Eur Urol. 2021 Apr;79(4):456-465. doi: 10.1016/j.eururo.2020.06.041. Epub 2020 Jul 3.

PMID: 32631746 

 Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.

Salami SS, Kaplan JB, Nallandhighal S, Takhar M, Tosoian JJ, Lee M, Yoon J, Hovelson DH, Plouffe KR, Kaffenberger SD, Schaeffer EM, Karnes RJ, Lotan TL, Morgan TM, George AK, Montgomery JS, Davenport MS, You S, Tomlins SA, Curci NE, Kim HL, Spratt DE, Udager AM, Palapattu GS.

JCO Precis Oncol. 2019 Jun 12;3:PO.19.00054. doi: 10.1200/PO.19.00054. eCollection 2019.

PMID: 32914029

 Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer.

Salami SS, Singhal U, Spratt DE, Palapattu GS, Hollenbeck BK, Schonhoft JD, Graf R, Louw J, Jendrisak A, Dugan L, Wang Y, Tomlins SA, Dittamore R, Feng FY, Morgan TM.

JCO Precis Oncol. 2019;3:PO.18.00352. doi: 10.1200/po.18.00352. Epub 2019 May 30.

PMID: 32832835

 Transcriptomic heterogeneity in multifocal prostate cancer.

Salami SS, Hovelson DH, Kaplan JB, Mathieu R, Udager AM, Curci NE, Lee M, Plouffe KR, de la Vega LL, Susani M, Rioux-Leclercq N, Spratt DE, Morgan TM, Davenport MS, Chinnaiyan AM, Cyrta J, Rubin MA, Shariat SF, Tomlins SA, Palapattu GS.

JCI Insight. 2018 Nov 2;3(21):e123468. doi: 10.1172/jci.insight.123468.

PMID: 30385730